THE UBIQUITIN PATHWAY IN CORNEAL SCARRING
THE UBIQUITIN PATHWAY IN CORNEAL SCARRING
批准号:
10581233
负责人:
AUDREY M BERNSTEIN
金额:
$36.68万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-01 至 2027-01-31
关键词:
3-DimensionalAcrylamidesActinsAcuteAffectAnimalsAnti-Inflammatory AgentsApoptosisAppearanceBindingBiological AssayBiological ModelsBlindnessBone MarrowBundlingCell AdhesionCell CommunicationCell NucleusCell surfaceCellsChronicCicatrixCoculture TechniquesCollagenCommunicationComplexCorneaCorneal InjuryCytoskeletonCytosolDataDepositionDevelopmentEncapsulatedEndocytosisEnvironmentEquilibriumExcisionExhibitsExtracellular MatrixFamily suidaeFibroblastsFibrosisFlow CytometryFoundationsG3BP1 geneGelGenetic TranscriptionGoalsHourHumanHydrogelsImmuneImmunohistochemistryIn Situ Nick-End LabelingInfectionInfection preventionInjuryIntegrin alphaVIntegrinsKnockout MiceLegal patentLigationMacrophageMediatingMediatorModelingMolecularMonocular BlindnessMusMyofibroblastNuclearOrgan Culture TechniquesOryctolagus cuniculusOutcomePTPRC genePathologicPathway interactionsPhasePhenotypePlayProteinsRecyclingResearchRoleSignal TransductionSmall Interfering RNASystemTP53 geneTestingTherapeuticTimeTissuesTransforming Growth Factor betaTraumaUbiquitinVisioncorneal regenerationcorneal scarimmune cell infiltratein vivoknock-downmouse modelnovelpreventresponsetherapeutic siRNAtissue repairubiquitin isopeptidasewoundwound healing
中文摘要
项目摘要:泛素途径在角膜瘢痕形成中的作用
由于损伤、创伤或感染导致的角膜疤痕可导致衰弱的混浊和
永久性视力丧失。急性瘢痕形成,类似于慢性纤维化,以免疫细胞为特征。
被称为肌成纤维细胞的细胞的浸润和持续存在。我们发现去泛素酶
(配音)USP10是角膜疤痕形成途径的关键调节因子。体内敲除USP10导联
能显著减少肌成纤维细胞的发育、细胞的凋亡、CD45+的存在
愈合伤口中的免疫细胞和纤维化的细胞外基质。我们提议测试中央
假设USP10是角膜瘢痕中肌成纤维细胞持久性的关键调节因子。
因子在伤口愈合中的作用。具体地说,由于USP10是αv-整合素和p53在特定情况下的配音
目的1我们将揭示USP10在整合素循环和p53动态中的复杂作用。
人角膜成纤维细胞和小鼠体内。成纤维细胞和成纤维细胞之间的通讯
巨噬细胞在瘢痕形成的结果中起着关键作用。在具体目标2中,我们将开发新的3D和
2.5D水凝胶系统,具有“可调节的硬度”,模拟3D环境,接近于
正在愈合的角膜。利用这些水凝胶,小鼠角膜成纤维细胞将与小鼠骨共同培养。
骨髓来源巨噬细胞(M0/M1/M2)中USP10在巨噬细胞介导中的作用
肌成纤维细胞的发育和收缩。在特定的目标3中,我们使用了三个单独的小鼠模型
将评估USP10在免疫细胞渗入角膜伤口中的作用。
英文摘要
Project Summary: The ubiquitin pathway in corneal scarring
Scarring in the cornea resulting from injury, trauma, or infection can lead to debilitating opacities and
permanent vision loss. Acute scarring, similar to chronic fibrosis, is characterized by immune cell
infiltration and the persistence of cells termed myofibroblasts. We have found that the deubiquitinase
(DUB) USP10 is a key regulator of scarring pathways in the cornea. Knockdown of USP10 in vivo leads
to a significant reduction in the development of myofibroblasts, cell apoptosis, the presence of CD45+
immune cells, and fibrotic extracellular matrix in a healing wound. We are proposing to test the central
hypothesis that USP10 is a key regulator of myofibroblast persistence in a corneal scar via its multi-
factorial role in wound healing. Specifically, since USP10 is a DUB for αv-integrins and p53, in Specific
Aim 1 we will unravel the complex role of USP10 in integrin recycling and p53 dynamics in primary
human corneal fibroblasts and in mice in vivo. The communication between fibroblasts and
macrophages plays a critical role in scarring outcomes. In Specific Aim 2 we will develop novel 3D and
2.5D hydrogel systems with “tunable stiffness” that mimic a 3D environment close to the stiffness of the
healing cornea. Using these hydrogels, mouse corneal fibroblasts will be cocultured with mouse bone
marrow derived macrophages (M0/M1/M2) to elucidate the role of USP10 in macrophage-mediated
myofibroblast development and contraction. In Specific Aim 3 using three separate mouse models we
will assess the role of USP10 in immune cell infiltration into a corneal wound.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1097/ijg.0000000000000606
发表时间:
2018-03
期刊:
Journal of glaucoma
影响因子:
2
作者:
[Wolosin JM, Ritch R, Bernstein AM]
通讯作者:
Bernstein AM
DOI:
10.1155/2016/5309484
发表时间:
2016
期刊:
Stem cells international
影响因子:
4.3
作者:
[Inthanon K, Daranarong D, Techaikool P, Punyodom W, Khaniyao V, Bernstein AM, Wongkham W]
通讯作者:
Wongkham W
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
-
批准号:10664929
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
-
批准号:10406147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:9980044
-
项目类别:
-
资助金额:$42.68万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10663210
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10160908
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Cellular Dysfunction in Exfoliation Glaucoma
-
批准号:10413111
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2020
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UBIQUITIN PATHWAY IN CORNEAL SCARRING
-
批准号:9482016
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2017
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7434324
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7238558
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7015385
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7844833
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7626280
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
Corneal Repair: uPA and extracellular matrix
-
批准号:7922944
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2006
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6518392
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2002
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6397748
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
THE UPA PATHWAY IN CORNEAL STROMA WOUND HEALING
-
批准号:6136366
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2000
-
负责人:AUDREY M BERNSTEIN
-
依托单位:
海外基金